Emerging Diseases News

As the COVID-19 pandemic enters its 4th year, its effect on children continues to be widely studied. We compiled a list of pediatric COVID-19 stories reported over the course of the past year.

We continue to be captivated by the stories you tell in our “Hooked on ID” series.

Reversing a trend of improvement from 1999 to 2019, CV mortality rates increased in the U.S. during the first year of the COVID-19 pandemic, with the highest increases among Black and Hispanic adults, according to researchers.

Malaria cases and deaths stabilized in 2021 after increasing in 2020 as the mosquito-borne disease took a back seat to COVID-19 and an exploding pandemic.

Protection against the omicron variant from the Pfizer-BioNTech COVID-19 vaccine waned after 3 months in children aged 5 to 11 years but was restored by a booster shot, according to study findings published in JAMA Network Open.

COVID-19 placed a strain on infection prevention and control programs, highlighting vulnerabilities that existed before the pandemic, according to experts.

I got into the medical field to solve problems, and the field of infectious diseases exemplifies that.

The manufacturers of the COVID-19 vaccines authorized for use as additional booster shots in the United States all released positive clinical trial data on their retooled shots ahead of the start of the holiday season.

The risk for severe disease or death among U.S. adults with COVID-19 was highest for unvaccinated inpatients and those infected with the delta variant, according to a recent study published in Clinical Infectious Diseases.

Experts argued for the development of COVID-19 vaccines that can be delivered at the site of infection, but questioned whether it is possible to make a mucosal vaccine that prevents SARS-CoV-2 infection — and not just severe disease.